Showing results (1-10 of 120) with videos related to
Sort By:
Pageof 12
Pharmacology, Biochemistry, and Behavior|October 6, 2009
Shock-induced aggression in mice is modified by lithiumColleen E Kovacsics, Todd D GouldAnnual Review of Pharmacology and Toxicology|October 7, 2008
Lithium's antisuicidal efficacy: elucidation of neurobiological targets using endophenotype strategiesColleen E Kovacsics, Irving I Gottesman, Todd D GouldBrain, Behavior, and Immunity|March 10, 2009
Allergic rhinitis induces anxiety-like behavior and altered social interaction in rodentsLeonardo H Tonelli, Morgan Katz, Colleen E Kovacsics, et al.Expert Opinion on Therapeutic Targets|May 19, 2006
Targeting glycogen synthase kinase-3 as an approach to develop novel mood-stabilising medicationsTodd D GouldNeuroscience and Biobehavioral Reviews|July 14, 2007
Animal models of bipolar disorder and mood stabilizer efficacy: a critical need for improvementTodd D Gould, Haim EinatGlia|May 26, 2017
Degradation of heme oxygenase-1 by the immunoproteasome in astrocytes: A potential interferon-γ-dependent mechanism contributing to HIV neuropathogenesisColleen E Kovacsics, Alexander J Gill, Surendra S Ambegaokar, et al.Journal of Virology|August 14, 2015
Induction of Heme Oxygenase-1 Deficiency and Associated Glutamate-Mediated Neurotoxicity Is a Highly Conserved HIV Phenotype of Chronic Macrophage Infection That Is Resistant to Antiretroviral TherapyAlexander J Gill, Colleen E Kovacsics, Patricia J Vance, et al.Journal of Psychosomatic Research|August 10, 2002
Signaling networks in the pathophysiology and treatment of mood disordersTodd D Gould, Husseini K ManjiThe American Journal of Psychiatry|April 2, 2003
The endophenotype concept in psychiatry: etymology and strategic intentionsIrving I Gottesman, Todd D GouldBiological Psychiatry|October 19, 2025
Intermittent Ketamine and Neuromodulation Treatment Evoke Synergistic Antidepressant-Relevant ActionKyle A Brown, Todd D GouldPageof 12